This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: University of Florida Research Foundation Inc., University of Pennsylvania. Active years: 2025.
Company Filing History:
1 out of 3,050 
1 out of 2,655 
Years Active: 2025
Title: Artur Cideciyan: Innovator in Retinal Disease Treatment
Introduction
Artur Cideciyan is a prominent inventor based in Lafayette Hill, PA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of genetic disorders affecting vision.
Latest Patents
Cideciyan holds a patent for "Compositions and methods for treatment of dominant retinitis pigmentosa." This patent focuses on methods and compositions that are useful for treating retinitis pigmentosa. The disclosure provides innovative approaches for delivering interfering RNA to reduce the expression of one or both alleles of an endogenous RHO gene, particularly targeting mutant alleles associated with retinitis pigmentosa. Additionally, the patent includes methods for delivering a replacement RHO coding sequence that is resistant to the interfering RNA.
Career Highlights
Throughout his career, Cideciyan has worked with esteemed institutions such as the University of Pennsylvania and the University of Florida Research Foundation Inc. His work has been pivotal in advancing the understanding and treatment of retinal diseases.
Collaborations
Cideciyan has collaborated with notable colleagues, including William Beltran and Gustavo D Aguirre. Their combined expertise has contributed to the development of innovative solutions in the field of retinal research.
Conclusion
Artur Cideciyan's work exemplifies the impact of innovation in medical science, particularly in the treatment of genetic eye disorders. His contributions continue to pave the way for advancements in ophthalmology and improve the lives of those affected by retinitis pigmentosa.